학술논문

Final results of BrUOG 354: A randomized phase II trial of nivolumab alone or in combination with ipilimumab for people with ovarian and other extra-renal clear cell carcinomas.
Document Type
Academic Journal
Source
Journal of Clinical Oncology (J CLIN ONCOL), 2024 Supplement 17; 42: LBA5500-LBA5500. (83p)
Subject
Language
English
ISSN
0732-183X